Search
Spotlight
AES 2020
Clinical Focus
Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke
Video Series
Cure Connections
Insights
News Network
Peer Exchange
Media
All Videos
Medical World News
News Articles
Podcasts
Weekly Recap
Conferences
Conference Coverage
Conference Listing
Partners
Resources
Education
Fellows' Corner
Interactive Tools
Neurology Resources
Publication
Virtual Events
Subscribe
Search
Spotlight
AES 2020
Clinical Focus
See All >
Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke
Video Series
Cure Connections
Insights
News Network
Peer Exchange
Optimal Management of OFF Episodes in Parkinson's Disease
home
Overview of OFF Episodes in Parkinson’s Disease
Apomorphine Subcutaneous Injection: Historical Perspective for Off-Episodes in Parkinson’s Disease
Apomorphine Subcutaneous Injection: Efficacy and Administration for Off-Episodes in Parkinson Disease
Apomorphine Subcutaneous Injection: Patient Selection for Off-Episodes in Parkinson Disease
Apomorphine Subcutaneous Injection: Circle of Care Program for Off-Episodes in Parkinson Disease
Recent Approval of Sublingual Apomorphine for Off-Episodes in Parkinson Disease
Continuous Subcutaneous Apomorphine Infusion in Development for OFF Episodes in Parkinson’s Disease
Levodopa Inhalation Powder for OFF Episodes in Parkinson’s Disease
Recently Approved Oral Therapies for OFF Episodes in Parkinson’s Disease
Device-Assisted and Surgical Options for Advanced Motor Fluctuations in Parkinson’s Disease
Treating OFF Episodes in Parkinson’s Disease During COVID-19
Next >>